https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-10-01 / Cancer Immunol Res 2013 Oct;1(4):210-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-10-01 / Cancer Immunol Res 2013 Oct;1(4):210-62013-10-01 00:00:002019-02-15 09:18:14Temperature matters! And why it should matter to tumor immunologists
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-09-01 / Colorectal Dis 2013 Sep;15(9):1107-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-09-01 / Colorectal Dis 2013 Sep;15(9):1107-142013-09-01 00:00:002019-02-15 08:39:14Phase II study of concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-08-01 / Immunology 2013 Aug;139(4):407-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-08-01 / Immunology 2013 Aug;139(4):407-152013-08-01 00:00:002019-02-15 08:48:29Heat-shock proteins as dendritic cell-targeting vaccines–getting warmer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-06-03 / Radiother Oncol 2013 Nov;109(2):188-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-06-03 / Radiother Oncol 2013 Nov;109(2):188-932013-06-03 00:00:002013-06-03 00:00:00Re-irradiation and hyperthermia after surgery for recurrent breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-04-30 / Int. J. Mol. Med. 2013 Jul;32(1):195-202
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-04-30 / Int. J. Mol. Med. 2013 Jul;32(1):195-2022013-04-30 00:00:002019-02-15 09:17:14Identification of common gene networks responsive to mild hyperthermia in human cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-04-14 / Evid Based Complement Alternat Med 2013;2013:672873
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-04-14 / Evid Based Complement Alternat Med 2013;2013:6728732013-04-14 00:00:002019-02-15 09:17:13Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-01-01 / Acupunct Electrother Res 2013;38(3-4):161-97
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-01-01 / Acupunct Electrother Res 2013;38(3-4):161-972013-01-01 00:00:002013-01-01 00:00:00Oncothermia: a new paradigm and promising method in cancer therapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-12-28 / J Med Case Rep 2012 Dec;6:427
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-12-28 / J Med Case Rep 2012 Dec;6:4272012-12-28 00:00:002012-12-28 00:00:00A seven-year disease-free survivor of malignant pleural mesothelioma treated with hyperthermia and chemotherapy: a case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-12-17 / Int J Hyperthermia 2013;29(1):8-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-12-17 / Int J Hyperthermia 2013;29(1):8-162012-12-17 00:00:002012-12-17 00:00:00Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-12-11 / Biol. Pharm. Bull. 2013;36(3):376-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-12-11 / Biol. Pharm. Bull. 2013;36(3):376-832012-12-11 00:00:002012-12-11 00:00:00Short-term hyperthermia promotes the sensitivity of MCF-7 human breast cancer cells to paclitaxel
